Detalhe da pesquisa
1.
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
Haematologica
; 109(4): 1107-1120, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37731380
2.
A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms.
Jpn J Clin Oncol
; 52(8): 880-886, 2022 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35575284
3.
Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.
BMC Infect Dis
; 21(1): 502, 2021 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34051752
4.
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.
Int J Clin Oncol
; 26(11): 2142-2150, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34259983
5.
Myalgia caused by chronic myositis associated with plasmacytosis: a case report.
BMC Neurol
; 18(1): 112, 2018 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30107829
6.
[Transfusion independence achieved with pomalidomide therapy in a patient with primary myelofibrosis].
Rinsho Ketsueki
; 59(3): 323-325, 2018.
Artigo
Japonês
| MEDLINE | ID: mdl-29618692
7.
[Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].
Rinsho Ketsueki
; 58(11): 2213-2218, 2017.
Artigo
Japonês
| MEDLINE | ID: mdl-29212971
8.
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
Ann Hematol
; 95(9): 1465-72, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27358178
9.
Clinical benefits of bortezomib-containing regimens for newly diagnosed AL amyloidosis with severe cardiac impairment.
Rinsho Ketsueki
; 57(8): 987-93, 2016 08.
Artigo
Japonês
| MEDLINE | ID: mdl-27599413
10.
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).
Int J Hematol
; 119(6): 707-721, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38548963
11.
Primary pleural of mucosa-associated lymphoid tissue lymphoma.
Rinsho Ketsueki
; 54(5): 463-7, 2013 05.
Artigo
Japonês
| MEDLINE | ID: mdl-23727685
12.
Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?
Case Rep Oncol
; 15(1): 7-11, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35221963
13.
Vitamin B6 deficiency as a cause of polyneuropathy in POEMS syndrome: rapid recovery with supplementation in two cases.
Hematology
; 27(1): 463-468, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35413228
14.
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin.
Case Rep Oncol
; 15(1): 263-266, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35431857
15.
Bosutinib-induced lung injury: a report of two cases and literature review.
Int J Hematol
; 115(6): 902-905, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35229254
16.
Immunohistochemical Detection of Aflatoxin in Lesions of Aflatoxin-producing Aspergillus flavus Infection.
Med Mycol J
; 62(3): 47-52, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34471034
17.
Improvement in the Symptoms and VEGF Levels after Resection of an Extrame Dullary Spinal Tumor and Additional Chemotherapy in a Patient with Multiple Myeloma Complicated with POEMS Syndrome.
Intern Med
; 60(22): 3625-3630, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34776466
18.
Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.
Eur J Haematol
; 84(4): 310-5, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20015242
19.
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma.
Mol Cancer Res
; 18(4): 632-643, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31974290
20.
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma.
Cancers (Basel)
; 11(11)2019 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31752356